BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38051965)

  • 1. The Relationship Between the Microbiome and Antimicrobial Resistance.
    Nhu NTQ; Young VB
    Clin Infect Dis; 2023 Dec; 77(Suppl 6):S479-S486. PubMed ID: 38051965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
    Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microbial consortium alters intestinal
    Rooney AM; Cochrane K; Fedsin S; Yao S; Anwer S; Dehmiwal S; Hota S; Poutanen S; Allen-Vercoe E; Coburn B;
    mBio; 2023 Aug; 14(4):e0348222. PubMed ID: 37404011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of live biotherapeutics against
    Zhang Y; Saint Fleur A; Feng H
    Gut Microbes; 2022; 14(1):2052698. PubMed ID: 35319337
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection.
    Straub TJ; Lombardo MJ; Bryant JA; Diao L; Lodise TP; Freedberg DE; Wortman JR; Litcofsky KD; Hasson BR; McGovern BH; Ford CB; Henn MR
    Clin Infect Dis; 2024 Apr; 78(4):833-841. PubMed ID: 37823484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome therapeutics for the treatment of recurrent
    Bloom PP; Young VB
    Expert Opin Biol Ther; 2023 Jan; 23(1):89-101. PubMed ID: 36536532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome.
    Gerardin Y; Timberlake S; Allegretti JR; Smith MB; Kassam Z
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S276-S282. PubMed ID: 33330910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut associated metabolites and their roles in
    Aguirre AM; Sorg JA
    Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microbiome-based therapeutics for the reduction and prevention of antimicrobial-resistant organism colonization.
    Mansoor AE; O'Neil CA; Kwon JH
    Anaerobe; 2023 Oct; 83():102772. PubMed ID: 37572864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics as Major Disruptors of Gut Microbiota.
    Ramirez J; Guarner F; Bustos Fernandez L; Maruy A; Sdepanian VL; Cohen H
    Front Cell Infect Microbiol; 2020; 10():572912. PubMed ID: 33330122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridioides difficile Biofilm.
    Vuotto C; Donelli G; Buckley A; Chilton C
    Adv Exp Med Biol; 2024; 1435():249-272. PubMed ID: 38175479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.